- Telehealth Visits
- Insurance plan information
Sue Yom, MD, PhD
Radiation Oncology • Otolaryngology- Telehealth Visits
- Insurance plan information
Sue Yom, MD, PhD
Radiation Oncology • Otolaryngology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Sue Yom is an expert in the radiation treatment and management of head, neck and lung cancers.
In her research, Yom studies chemoradiation (a combination of chemotherapy and radiation) for these cancers. She also investigates image-guided radiation therapy and ways to reduce toxic effects using focused radiation techniques, emerging biological agents and radiation protectants.
Yom earned her medical and doctoral degrees at the University of Pennsylvania. She completed a residency in radiation oncology at the MD Anderson Cancer Center.
Yom has received numerous awards recognizing her commitment to patient care and patient-oriented research.
Education & training
Board certification
- Radiation Oncology, American Board of Radiology
Residency
- Radiation Oncology, University of Texas Health Science Ctr - Houston
Internship
- Internal Medicine, University of Texas Health Science Center
Degree
- MD, University of Pennsylvania School of Medicine
My expertise
Specialties
Conditions
- Plantar-Fascial Fibromatosis
- Dupuytren Contracture
- Hyperthermia
- Eye Cancer
Treatments
- Radiation Treatment
- 3D Conformal Radiation Therapy
- Volumetric Modulated Arc Therapy
- Stereotactic Spine Radiosurgery
- Intensity-Modulated Radiation Therapy
- CyberKnife
- Total Body Irradiation
- Stereotactic Cranial Radiation
- Gamma Knife Radiosurgery
Locations
My research
Clinical trials
Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR TrialOpens in a new window
Recruiting
Assessed using RECIST v1.1 and Kaplan-MeierAddressing Taste Dysfunction With Miraculin in Head and Neck Cancer Patients Receiving Radiation TherapyOpens in a new window
Recruiting
The Taste Assessment is a two-item questionnaire used to determine the overall experiences of the participant taste sensation in the past 7 days; with one…Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)Opens in a new window
Recruiting
Dose-limiting toxicities (DLTs) are defined in Section 5.2.3. DLT determination will assess adverse events (AEs) graded according to CTCAE v5.0, including…
Publications
Showing 1-6 of 44 reviews
- January 22, 20265 out of 5 Stars
Dr Yom brilliant and perfect in all areas of expertise and care
- January 7, 20265 out of 5 Stars
Dr. Yom is amazing. I'm so grateful to have her watching over me and my health!
- January 6, 20265 out of 5 Stars
Personable, detailed
- January 6, 20265 out of 5 Stars
Dr Yom is,of course, the very best and my favorite
- December 9, 20255 out of 5 Stars
Dr, was fantastic as usual. But was under weather- hope she is better today
- November 23, 20255 out of 5 Stars
Provider was both very personable and professional.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.